Insiders who reported open-market trades in the last 12 months at the companies Stephen P. Robertson files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Kevin Tang - $25.14M in AUPH purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Stephen P. Robertson is a corporate insider, tracked as Chief Legal Officer of Aurinia Pharmaceuticals Inc. (AUPH). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Stephen P. Robertson submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has Stephen P. Robertson been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($546K) across all tracked filings.
Stephen P. Robertson is Chief Legal Officer of Aurinia Pharmaceuticals Inc. (AUPH). 5 SEC Form 4 filings on record, most recently on 11 September 2026. Most recent open-market trade: sold $190K of AUPH on 11 September 2026. Lifetime open-market sales: $546K.
Recent transactions
6
The latest 6 SEC Form 4 transactions reported by Stephen P. Robertson.
InsiderAlpha's records for Stephen P. Robertson go back to 2026: 5 primary Form 4 filings, an average of 5.0 per year. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
